Browse Category

Investment Analysis News 13 December 2025 - 14 December 2025

Westpac (ASX: WBC) Share Price: This Week’s Moves, Latest News, Analyst Forecasts and the Week Ahead (Updated 14 Dec 2025)

Westpac (ASX: WBC) Share Price: This Week’s Moves, Latest News, Analyst Forecasts and the Week Ahead (Updated 14 Dec 2025)

Updated: 14 December 2025 (Sunday) — Australian markets last traded on Friday, 12 December. markets.ft.markitdigital.com Westpac Banking Corporation’s shares ended the week on a firmer note, but the story behind the ticker has been less about a single macro headline and more about a cluster of very “bank in 2025” issues: operational resilience (an EFTPOS/online disruption in peak Christmas trading), governance scrutiny at the AGM, and a shifting interest-rate narrative that keeps re-pricing the entire Australian bank sector. Below is a detailed recap of what moved Westpac (ASX: WBC) this week, what analysts are forecasting now, and the key catalysts
Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings Ltd. (NYSE: NU) — the parent of Nubank — closed Friday, Dec. 12, 2025 at about $16.90, ending a steadier week after early-December volatility. Investing.com For investors tracking NU stock into next week, the story is less about a single earnings headline (Nu’s next results are still months away) and more about a regulatory-driven banking license push in Brazil, a fresh growth milestone in Colombia, and a macro backdrop dominated by Latin American interest-rate signals. Reuters+3SEC+3Nu International+3 NU stock performance this week: grinding higher after the Dec. 5 drop After a sharp selloff on Dec. 5 (a session
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close). Destiny Tech100 Inc. (NYSE: DXYZ) just posted a sharp, high-volume run-up as investor attention snapped back to one theme: SpaceX IPO speculation—and what it could mean for public-market “access” vehicles tied to private tech leaders. But DXYZ isn’t a conventional operating company stock. It’s a closed-end management investment company built to hold a portfolio of late-stage private tech names, and it can trade far away from the value of its underlying assets (NAV). Destiny+1 Below is a detailed, publication-ready breakdown of this week’s move (Dec. 8–12), the most important news from the last
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage cardiovascular company. GlobeNewswire+1 The stock action was anything but calm. MIST closed at $2.41 on Dec. 12, down 18.31%, after swinging through a wide intraday range and printing exceptionally heavy volume. After-hours trading showed a modest rebound. StockAnalysis Below is a detailed breakdown of the latest Milestone Pharmaceuticals news, this week’s trading story, forecasts and analyst targets, and the week-ahead
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) closed at $81.65 on Dec. 12 after a headline-heavy week featuring new Google Cloud and Meta agreements, raised 2025–2026 EPS guidance, and fresh analyst price targets. NextEra Energy, Inc. (NYSE: NEE) ended Friday, Dec. 12, 2025, at $81.65. Yahoo Finance That close caps a volatile, news-packed week in which the company leaned hard into a single message for investors: power demand is accelerating, and the fastest-growing customers are increasingly AI and data-center developers—a trend NextEra believes can translate into multi-year earnings and dividend growth. NextEra Energy Investor Relations+1 Below is a complete, publication-ready breakdown of what moved
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the spotlight for America’s largest for-profit hospital operator. StockAnalysis+2MarketWatch+2 Below is what moved HCA stock this week, the most important HCA Healthcare news from the past several days, what analysts are forecasting now, and the key catalysts to watch in the week ahead. HCA stock this week: flat finish, big intrawEEK volatility HCA ended Friday (Dec. 12) at $484.77, up 0.50%
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin Corporation (NYSE: LMT) wrapped up the week with a strong move higher, closing at $480.25 on Friday, December 12, 2025, extending a nine-session winning streak even as broader U.S. equities finished the day lower. MarketWatch+1 For investors tracking LMT stock into next week, the story is a mix of momentum, contract-driven visibility, and headline risk—especially around the F-35 program after Switzerland said it will trim its planned purchase to stay within budget. Reuters Below is a detailed, Google News/Discover-ready roundup of what moved Lockheed Martin stock this week, the most important news from the last several days, updated
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Updated: Friday, December 12, 2025Ticker: Starbucks Corporation (NASDAQ: SBUX) Starbucks stock ended the week on a steadier note after a choppy stretch that included a sharp early-week dip and a rebound into Friday’s close. Heading into next week, investors are weighing three near-term forces: labor headlines (as the workers’ strike expands), operational initiatives tied to CEO Brian Niccol’s “Back to Starbucks” turnaround, and macro data that can swing consumer-facing names. SBUX closed Friday, Dec. 12 at $85.35, up modestly from last Friday’s $85.12, after falling as low as $82.28 on Tuesday before recovering across the rest of the week. Starbucks
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) finished Friday at $452.04, extending a late-week rebound after a choppy start to the week. The stock’s intraday range on Friday stretched from $442.94 to $455.99 on volume of about 1.62 million shares, as biotech investors weighed fresh pipeline headlines, Wall Street price-target moves, and a shifting macro backdrop following the Federal Reserve’s latest rate decision. MarketWatch+1 Below is a detailed, publication-ready breakdown of all notable VRTX news from the past several days, the latest analyst forecasts, and what could matter most for next week’s trading. VRTX stock
Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Parker-Hannifin Corporation (NYSE: PH) wrapped up a volatile week still sitting near fresh highs after a rapid run-up earlier in the week. Shares closed Friday at $884.87, down 1.59% on the day, after setting a new 52-week high of $901.31 on Dec. 11. Trading volume on Dec. 12 came in below the stock’s 50-day average, suggesting a bout of profit-taking rather than a broad rush for the exits. MarketWatch The main “bigger picture” narrative behind Parker-Hannifin stock remains unchanged: strong operating momentum (especially in aerospace), a raised fiscal-year outlook, and a major portfolio
Arista Networks Stock Forecast: ANET Slumps After a 7‑Day Rally as AI Spending Jitters Return — What to Watch Next Week (Updated Dec. 12, 2025)

Arista Networks Stock Forecast: ANET Slumps After a 7‑Day Rally as AI Spending Jitters Return — What to Watch Next Week (Updated Dec. 12, 2025)

Arista Networks, Inc. (NYSE: ANET) ended Friday, December 12, 2025, at $124.76, sliding 7.17% and snapping a seven-session winning streak just one day after closing at $134.39. MarketWatch+1The selloff arrived as the broader “AI trade” turned volatile again, after disappointing updates from major AI-linked names reignited investor concerns about the pace, cost, and timing of data-center buildouts. Reuters Below is a detailed, news-driven look at what moved ANET stock this week, the latest Arista Networks headlines, where analysts see the stock going, and the key catalysts to watch in the week ahead (Dec. 15–19, 2025). ANET stock this week: from
1 165 166 167 168 169 282

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:27 AM EST Dollar Dips as Stocks Rally and US Data Influences Fed Rate Expectations February 7, 2026, 12:18 AM EST. The **dollar index** fell 0.17%, pressured by a rebound in equity markets reducing demand for the safe-haven currency. Weaker-than-expected U.S. labor market data raised the odds of a Fed rate cut to 18% for March, though consumer sentiment improved to a six-month high, limiting losses. Hawkish comments from Atlanta Fed's Raphael Bostic emphasized maintaining restrictive monetary policy. The dollar faces medium-term weakness amid expectations for rate cuts
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop